398 related articles for article (PubMed ID: 22530690)
1. Ocular application of chitosan.
Başaran E; Yazan Y
Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
[TBL] [Abstract][Full Text] [Related]
2. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review.
Irimia T; Dinu-Pîrvu CE; Ghica MV; Lupuleasa D; Muntean DL; Udeanu DI; Popa L
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30304825
[TBL] [Abstract][Full Text] [Related]
4. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
Agrawal AK; Das M; Jain S
Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
[TBL] [Abstract][Full Text] [Related]
5. Chitosan and its role in ocular therapeutics.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Mini Rev Med Chem; 2009 Dec; 9(14):1639-47. PubMed ID: 20105127
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
[TBL] [Abstract][Full Text] [Related]
7. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
8. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
[TBL] [Abstract][Full Text] [Related]
9. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
10. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
11. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
Pontillo ARN; Detsi A
Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
[TBL] [Abstract][Full Text] [Related]
13. Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations.
Almeida H; Amaral MH; Lobão P; Silva AC; Loboa JM
J Pharm Pharm Sci; 2014; 17(3):278-93. PubMed ID: 25224343
[TBL] [Abstract][Full Text] [Related]
14. In situ gelling polymers in ocular drug delivery systems: a review.
Mundada AS; Avari JG
Crit Rev Ther Drug Carrier Syst; 2009; 26(1):85-118. PubMed ID: 19496748
[TBL] [Abstract][Full Text] [Related]
15. In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions.
Gonzalez-Pizarro R; Carvajal-Vidal P; Halbault Bellowa L; Calpena AC; Espina M; García ML
Colloids Surf B Biointerfaces; 2019 Mar; 175():365-374. PubMed ID: 30554015
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
17. Chitosan nanoparticles for drug delivery to the eye.
Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
[TBL] [Abstract][Full Text] [Related]
20. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
